中国医学伦理学2017，Vol.30Issue(5)：572-575,4.DOI:10.12026/j.issn.1001-8565.2017.05.12
论如何在药物临床试验中保护弱势群体
How to Protect the Vulnerable Groups in Drug Clinical Trials
摘要
Abstract
Objective:To find a better way to protect the security and interests of vulnerable groups by exploring the problem of protecting the vulnerable groups in drug clinical trial from the perspectives of ethics committees,organization and researchers.Methods:According to the relevant literature and the actual situation of the hospital,this paper analyzed the security issues of vulnerable groups comprehensively.Results:Only the ethics committees,organization and researchers work together,can it protect the security and interests of vulnerable groups to the greatest extents.Conclusion:Further research on the security of vulnerable groups not only promotes the development of human health,but also plays a decisive role in improving the protection of subjects in drug clinical trial.关键词
药物临床试验/弱势群体/伦理委员会/受试者Key words
Drug Clinical Trial/Vulnerable Groups/Ethics Committee/The Subjects分类
医药卫生引用本文复制引用
林昕,周欣..论如何在药物临床试验中保护弱势群体[J].中国医学伦理学,2017,30(5):572-575,4.
